GHRS Latest Headlines

GH Research Highlights Federal Support for Psychedelic Depression Treatments as Phase 3 Readiness Advances

Market Chameleon (Mon, 20-Apr 11:07 AM)

GH Research Poised for Next-Gen Depression Treatment as White House Executive Order Bolsters Psychedelic Therapies Initiative

Market Chameleon (Mon, 20-Apr 9:17 AM)

H.C. Wainwright Keeps Their Buy Rating on GH Research (GHRS)

at www.tipranks.com (Mon, 20-Apr 1:36 PM)

Biggest stock movers Monday: Psychedelic stocks, BLD, USAR, and more

at seekingalpha.com (Mon, 20-Apr 10:00 AM)

Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research

at seekingalpha.com (Mon, 20-Apr 7:31 AM)

Biggest stock movers Monday: Psychedelic stocks and more

at seekingalpha.com (Mon, 20-Apr 5:41 AM)

Psychedelic stocks rally after Trump orders faster PTSD research; Compass Pathways, Atai lead gains

at seekingalpha.com (Mon, 20-Apr 5:03 AM)

Trump issues executive order on psychedelic drugs

at seekingalpha.com (Sat, 18-Apr 9:57 AM)

GH Research’s Phase 2b Success in Depression Marks Major Milestone—$280.7M Cash Runway Backs Phase 3 Ambitions

Market Chameleon (Thu, 5-Mar 9:10 AM)